Weight Loss
Medical Weight Loss
A medically managed weight loss program is a comprehensive approach to weight loss that involves the supervision and guidance of healthcare professionals. This type of program is designed to address the specific needs and health conditions of individuals seeking to lose weight.
The goal of a medically managed weight loss program is to promote safe and sustainable weight loss while addressing underlying health issues. It emphasizes a holistic approach that considers both physical and mental well-being. Individuals considering such programs should consult with our healthcare professional to determine the most suitable approach for their unique circumstances.
Criteria:
BMI > 30 kg/m2 or greater
BMI 27 kg/m2 or greater with weight related comorbidity such as Hypertension, Hypercholesterolemia or Type 2 Diabetes Mellitus
Key Components
Medical Assessment
A thorough evaluation of an individual’s overall health, medical history, and any existing conditions that may impact weight loss.
Customized Plan
Physical Activity
Medication Management
In some cases, medications may be prescribed to aid weight loss. This could include medications like Semaglutide, which has been approved for weight management.
Regular Monitoring
Ongoing monitoring of progress, adjustments to the plan as needed, and addressing any challenges or concerns that may arise during the weight loss journey.
Semaglutide
Semaglutide belongs to a class of drugs known as GLP-1 receptor agonists. Semaglutide works by mimicking the effects of a natural hormone, GLP-1, which helps regulate blood sugar levels.
Semaglutide has been approved for use in weight management, specifically for adults with obesity or overweight conditions who also have weight-related health issues.
Patients typically inject Semaglutide once a week as part of a comprehensive weight loss program that includes a calorie-controlled diet and increased physical activity.
Tirzepatide
Tirzepatide belongs to a class of drugs known as dual glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonists.
Tirzepatide can slow down gastric emptying and induce a sense of fullness, contributing to potential weight loss benefits.
Patients typically administer Tirzepatide through once a week subcutaneous injections, and its use for weight loss is often part of a comprehensive program that includes lifestyle modifications such as a calorie-controlled diet and increased physical activity.
Tirzepatide
Tirzepatide belongs to a class of drugs known as dual glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonists.
Tirzepatide can slow down gastric emptying and induce a sense of fullness, contributing to potential weight loss benefits.
Patients typically administer Tirzepatide through once a week subcutaneous injections, and its use for weight loss is often part of a comprehensive program that includes lifestyle modifications such as a calorie-controlled diet and increased physical activity.
FAQs
How can I know if medical weight loss is for me?
Determining if medical weight loss is suitable for you involves consulting with a healthcare professional. Factors considered include your overall health, medical history, current medications, and weight loss goals.
If you have struggled with traditional methods like diet and exercise, or if you have obesity-related health issues, medical weight loss might be an option. Our healthcare provider can assess your individual situation and discuss potential benefits, risks, and available options to help you make an informed decision.
What other weight loss medications are offered aside from injections?
How are the weight loss injections adminstered?
Both Semaglutide and Tirzepatide are administered through subcutaneous injections. Typically injected once a week. Dosing frequency varies, determined by our Nurse Practitioner.
How much weight can I expect to lose?
Results depend on factors such as adherence to the treatment plan, individual metabolism, lifestyle, and other health considerations. In clinical studies, some participants achieved a weight loss of 5-15% of their initial body weight over a specified period.
What are contraindications to Semaglutide and Tirzepatide?
It’s essential to consult with a healthcare professional for personalized advice, but here are some general contraindications: personal or family history of Medullary Thyroid Carcinoma (MTC), history of Multiple Endocrine Neoplasia Syndrome Type 2 (MEN 2). Other contraindications include a history of pancreatitis, decreased kidney function or gallbladder disease.